These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 6885054)
1. Characterization of weak alleles at the DIA1 locus (Mustapha 1, Mustapha 2, and Mustapha 3) in the Algerian population. Reghis A; Troungos C; Lostanlen D; Krishnamoorthy R; Kaplan JC Hum Genet; 1983; 64(2):173-5. PubMed ID: 6885054 [TBL] [Abstract][Full Text] [Related]
2. Quantitative variations of red-cell cytochrome b5 reductase (NADH-methemoglobin-reductase) in the Algerian population: evidence for defective alleles. Reghis A; Benabadji M; Tchen P; Kaplan JC Hum Genet; 1981; 59(2):148-55. PubMed ID: 7327574 [TBL] [Abstract][Full Text] [Related]
3. [Hereditary methemoglobinemia due to NADH cytochrome b5 abnormality--clinical importance of the enzyme in leukocytes and platelets]. Tomita Y; Inagaki M; Taki M; Miura T; Saito N; Meguro T; Yamada K; Fujii H; Takizawa T; Miwa S Rinsho Ketsueki; 1986 Mar; 27(3):412-9. PubMed ID: 3735692 [No Abstract] [Full Text] [Related]
13. Alteration of NADH-diaphorase and cytochrome b5 reductase activities of erythrocytes, platelets, and leucocytes in hereditary methaemoglobinaemia with and without mental retardation. Takeshita M; Matsuki T; Tanishima K; Yubisui T; Yoneyama Y; Kurata K; Hara N; Igarashi T J Med Genet; 1982 Jun; 19(3):204-9. PubMed ID: 6896729 [TBL] [Abstract][Full Text] [Related]
14. Concentration of NADH-cytochrome b5 reductase in erythrocytes of normal and methemoglobinemic individuals measured with a quantitative radioimmunoblotting assay. Borgese N; Pietrini G; Gaetani S J Clin Invest; 1987 Nov; 80(5):1296-302. PubMed ID: 3680497 [TBL] [Abstract][Full Text] [Related]
15. [Cell differentiation, maturation and enzyme abnormality--studies on NADH-cytochrome b5 reductase]. Takeshita M; Yubisui T Rinsho Ketsueki; 1986 Jul; 27(7):1138-44. PubMed ID: 3783996 [No Abstract] [Full Text] [Related]
16. [Clinical significance of cytochrome b5 reductase analysis in blood cell chemical tests]. Takeshita M Nihon Rinsho; 1989 Dec; 48 Suppl():982-4. PubMed ID: 2622040 [No Abstract] [Full Text] [Related]
18. A case of methemoglobinemia type II due to NADH-cytochrome b5 reductase deficiency: determination of the molecular basis. Aalfs CM; Salieb-Beugelaar GB; Wanders RJ; Mannens MM; Wijburg FA Hum Mutat; 2000; 16(1):18-22. PubMed ID: 10874300 [TBL] [Abstract][Full Text] [Related]
19. [Genetics and biochemistry of NADH-cytochrome b5 reductase deficiency]. Shirabe K Nihon Rinsho; 1999 Sep; 57 Suppl():769-71. PubMed ID: 10543233 [No Abstract] [Full Text] [Related]
20. Exponential decay of cytochrome b5 and cytochrome b5 reductase during senescence of erythrocytes: relation to the increased methemoglobin content. Takeshita M; Tamura M; Yubisui T; Yoneyama Y J Biochem; 1983 Mar; 93(3):931-4. PubMed ID: 6874674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]